Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects

Department of Medical Sciences, Cardiology, Uppsala University Hospital, S-751 85 Uppsala, Sweden.
European Heart Journal (Impact Factor: 15.2). 08/2008; 29(18):2252-8. DOI: 10.1093/eurheartj/ehn327
Source: PubMed


To evaluate the prevalence of cardiac troponin I (cTnI) elevation in an elderly community population and the association of cTnI levels with cardiovascular risk factors, vascular inflammation, atherosclerosis, cardiac performance, and areas indicative of infarcted myocardium identified by cardiac magnetic resonance imaging.
cTnI elevation defined as cTnI levels >0.01 microg/L (Access AccuTnI, Beckman Coulter) was found in 21.8% of the study participants (n = 1005). cTnI > 0.01 microg/L was associated with cardiovascular high-risk features, the burden of atherosclerosis in the carotid arteries, left-ventricular mass, and impaired left-ventricular systolic function. No associations were found between cTnI and inflammatory activity, diastolic dysfunction, or myocardial scars. Male gender (OR 1.6; 95% CI 1.1-2.4), ischaemic ECG changes (OR 1.7; 95% CI 1.1-2.7), and NT-pro-brain natriuretic peptide levels (OR 1.4; 95% CI 1.1-1.7) independently predicted cTnI > 0.01 microg/L. cTnI > 0.01 microg/L correlated also to an increased cardiovascular risk according to the Framingham risk score.
cTnI > 0.01 microg/L is relatively common in elderly subjects and is associated with cardiovascular high-risk features and impaired cardiac performance. Cardiac troponin determined by a highly sensitive assay might thus serve as an instrument for the identification of subjects at high cardiovascular risk in general populations.

Download full-text


Available from: Bertil Lindahl,
  • Source
    • "Elevation of cardiac troponin is frequently observed in patients without significant coronary lesions, although the mechanism underlying this finding remains unclear.10) The aim of our study was to evaluate the association between the levels of cardiac troponin and CFR. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and Objectives Cardiac troponins are associated with increased mortality, even among patients with no coronary artery disease. Elevated cardiac troponin levels are frequently observed in patients without significant coronary lesions, although the mechanism underlying this finding is unclear. The aim of our study was to evaluate the association between the levels of cardiac troponin and coronary flow reserve (CFR). Subjects and Methods We evaluated serum cardiac troponin-I in 19 patients (9 female; age 61.9±10.9 year-old). All patients had an ejection fraction >40% and angiographically normal coronary arteries. Simultaneous measurements of fractional flow reserve (FFR), the index of microcirculatory resistance (IMR), and CFR measurements using an intracoronary temperature- and pressure-sensing guidewire under basal conditions and during maximal hyperemia were performed in three vessels: the left anterior descending artery (LAD), left circumflex artery (LCX) and right coronary artery (RCA). Results All patients were followed for a median of 13 months. FFR, IMR, and CFR measurements were performed successfully in all subjects. Mean CFRs of LAD, LCX, and RCA were 1.98±1.20, 2.75±2.11, and 4.44±2.51, respectively. Mean IMRs of LAD, LCX and RCA were 33.28±18.78, 29.11±26.70, and 30.55±23.65, respectively. There was a poor correlation between CFR and troponin-I values in each vessel. In selecting the lowest value of CFR in each patient as the corresponding value, the lowest CFR was not associated with troponin-I levels (r=-0.219, p=0.367). Conclusion In patients without significant coronary lesions, the correlation between CFR and troponin-I level was not significant using a thermodilution technique. Further study of a larger population with longer-term follow-up may be needed to more fully understand microvascular dysfunction.
    Korean Circulation Journal 05/2014; 44(3):141-7. DOI:10.4070/kcj.2014.44.3.141 · 0.75 Impact Factor
  • Source
    • "These measurable troponin levels are likely a result of cardiomyocyte necrosis and apoptosis41 and may therefore be a sensitive marker of cardiac physiology and potentially result from different subtle clinical derangements that stress the heart but are otherwise difficult to quantify due to their heterogeneous nature. Such a function is supported by the observation of an association between troponin levels in the normal range and different cardiovascular risk factors and subclinical atherosclerotic disease.42 Further insight into the link between troponin elevation and recurrent events might be gained by comparing the predictive power of troponin levels between different aetiological subgroups (eg, according to the TOAST classification). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and purpose Clinical scores are recommended for predicting cardiovascular risk in patients with cerebral ischaemia to inform secondary prevention. Blood biomarkers may improve prediction beyond clinical scores. Methods Within the observational Find-AF trial (ISRCTN46104198), 197 patients >18 years of age with cerebral ischaemia and without atrial fibrillation had blood sampled at baseline. The predictive value of five biomarkers for a combined vascular endpoint (acute coronary syndrome, stroke, cardiovascular death) and all-cause mortality was determined, alone and in addition to the Essen Stroke Risk Score (ESRS), Stroke Prognostic Instrument 2 (SPI-2) and National Institutes of Health Stroke Scale (NIH-SS). Results There were 23 vascular events (11.7%) and 13 deaths (6.6%) to 1 year follow-up. In multivariate analyses of all markers, only high-sensitivity troponin T (hsTropT) remained independently predictive for vascular events (p=0.045) and all-cause mortality (p=0.004). hsTropT was higher in patients with a vascular event (median 12.7 ng/ml vs 5.1 ng/ml), and patients with hsTropT above the median of 6.15 ng/ml had vascular events more frequently (HR 3.86, p=0.008). For prediction of vascular events as well as all-cause mortality, hsTropT significantly improved multivariate Cox regression models with ESRS, SPI-2 or NIH-SS. The c-statistic increased non-significantly from 0.695 (ESRS) or 0.710 (hsTropT) to 0.747 (ESRS+hsTropT) and from 0.699 (SPI-2) to 0.763 (SPI-2+hsTropT). No patient with a low-risk ESRS and an hsTropT below the median had a vascular event or died. Conclusions hsTropT predicts vascular events and all-cause mortality in patients with acute cerebral ischaemia and improves prediction beyond established clinical scores.
    Journal of neurology, neurosurgery, and psychiatry 01/2013; 84(5). DOI:10.1136/jnnp-2012-303360 · 6.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The presence of the cardiospecific cardiac troponins (cTns) I (cTnI) and T (cTnT) alongside signs or symptoms of myocardial infarction (MI) are indicative of an acute MI. As these proteins are not typically found in the sera of healthy individuals, any concentration of cTns exceeding the 99th percentile is interpreted as myocardial necrosis. Recently, new cTnI and cTnT with increased sensitivity and precision have been introduced to improve the detection and diagnosis of acute MI, the newest of which, the Elecsys® Troponin T highly sensitive assay, has demonstrated a particular advantage with high precision even in the 99th percentile. These enhanced properties are expected to increase the incidence of MI diagnoses, but currently it is not clear how to approach therapy in response to the detection of cTnT levels. The detection of elevated cTn levels alone is not sufficient for a diagnosis of acute MI, and requires an in-depth assessment of clinical presentation to determine the source and severity of myocardial damage.
    European Cardiology 01/2009; 5(2). DOI:10.15420/ECR.2009.5.2.44
Show more